EUVIMEDEUVIMED entdecken
Mixed-Methods-StudieOpen Access

The Asthma App as a New Way to Promote Responsible Short-Acting Beta2-Agonist Use in People With Asthma: Results of a Mixed Methods Pilot Study

Liselot N van den Berg iD, Cynthia Hallensleben iD, Lisa Ae Vlug iD, Niels H Chavannes iD, Anke Versluis iD

JMIR Human Factors · 2024

DOI: 10.2196/54386 ↗

Kurz gefasst

Mixed-Methods-Studie in der Zeitschrift JMIR Human Factors, 2024. Verfasst von Liselot N van den Berg und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands. Hauptthemen laut MEDLINE: Asthma, Drug-Related Side Effects and Adverse Reactions, Mobile Applications, Rhinitis, Allergic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Approximately 262 million people worldwide are affected by asthma, and the overuse of reliever medication—specifically, short-acting beta2-agonist (SABA) overuse—is common. This can lead to adverse health effects. A smartphone app, the Asthma app, was developed via a participatory design to help patients gain more insight into their SABA use through monitoring and psychoeducation.

Objective

This pilot study aims to evaluate the feasibility and usability of the app. The preliminary effects of using the app after 3 months on decreasing asthma symptoms and improving quality of life were examined.

Methods

A mixed methods study design was used. Quantitative data were collected using the app. Asthma symptoms (measured using the Control of Allergic Rhinitis and Asthma Test) and the triggers of these symptoms were collected weekly. Quality of life (36-Item Short-Form Health Survey) was assessed at baseline and after 3, 6, and 12 months. User experience (System Usability Scale) was measured at all time points, except for baseline. Furthermore, objective user data were collected, and qualitative interviews, focusing on feasibility and usability, were organized. The interview protocol was based on the Unified Theory of Acceptance and Use of Technology framework. Qualitative data were analyzed using the Framework Method.

Results

The baseline questionnaire was completed by 373 participants. The majority were female (309/373, 82.8%), with a mean age of 46 (SD 15) years, and used, on average, 10 SABA inhalations per week. App usability was rated as good: 82.3 (SD 13.2; N=44) at 3 months. The Control of Allergic Rhinitis and Asthma Test score significantly improved at 3 months (18.5) compared with baseline (14.8; β=.189; SE 0.048; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaDrug-Related Side Effects and Adverse ReactionsMobile ApplicationsRhinitis, AllergicFemaleHumansMaleMiddle AgedPilot ProjectsQuality of LifeAdult

Stichwörter der Autor:innen

SABA overuseappasthmaeHealthfeasibilitymobile phoneshort-acting beta2-agonistusability

Autor:innen und Institutionen

  • Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands.
  • National eHealth Living Lab, Leiden, Netherlands.

ORCID-Profile: Liselot N van den Berg, Cynthia Hallensleben, Lisa Ae Vlug, Niels H Chavannes, Anke Versluis

Zitieren

APA

van den Berg, L. N., Hallensleben, C., Vlug, L. A., Chavannes, N. H., & Versluis, A. (2024). The Asthma App as a New Way to Promote Responsible Short-Acting Beta2-Agonist Use in People With Asthma: Results of a Mixed Methods Pilot Study. JMIR Human Factors. https://doi.org/10.2196/54386

Vancouver

van den Berg LN, Hallensleben C, Vlug LA, Chavannes NH, Versluis A. The Asthma App as a New Way to Promote Responsible Short-Acting Beta2-Agonist Use in People With Asthma: Results of a Mixed Methods Pilot Study. JMIR Human Factors. 2024. doi:10.2196/54386

BibTeX
@article{vandenBerg2024,
  author = {van den Berg, Liselot N and Hallensleben, Cynthia and Vlug, Lisa Ae and Chavannes, Niels H and Versluis, Anke},
  title = {The Asthma App as a New Way to Promote Responsible Short-Acting Beta2-Agonist Use in People With Asthma: Results of a Mixed Methods Pilot Study},
  journal = {JMIR Human Factors},
  year = {2024},
  doi = {10.2196/54386}
}
Kostenlos starten →